Orthostatic Hypotension Clinical Trial
Official title:
Autonomic Effects of Transcutaneous Spinal Cord Stimulation in Veterans With Spinal Cord Injury (SCI)
NCT number | NCT05960448 |
Other study ID # | 1727500 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | July 30, 2023 |
Est. completion date | July 30, 2026 |
The goal of this interventional crossover study is to determine the effects of transcutaneous spinal cord stimulation (TSCS) on the ability to perform moderate exercise and regulate core body temperature in the chronic spinal cord injury community. The main questions it aims to answer are: - What are the effects of active TSCS targeted for BP control on exercise endurance time and HR recovery during submaximal arm cycle ergometry (ACE) as compared to sham TSCS in participants with chronic, cervical SCI? - What are the effects of active TSCS on Tcore responses to cool ambient exposure and on subjective reporting of thermal comfort and thermal sensitivity as compared to sham TSCS. Participants will receive sham and active stimulation while using an arm bicycle or while in a cold room. Participants are free to participate in either the exercise phase, the cold room phase, or both phases of this study. Please note that there no expected long term benefits of this study.
Status | Recruiting |
Enrollment | 20 |
Est. completion date | July 30, 2026 |
Est. primary completion date | July 30, 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - You are above the age of 18 years old - You have an SCI between C3-T6 - You have been injured longer than 1 year - You participated in a prior experiment "Targeted Transcutaneous Spinal Cord Stimulation to Restore Autonomic Cardiovascular Health in Individuals with Spinal Cord Injury" - You have an American Spinal Injury Association injury classification scale (AIS) A, B, C - Your prescription medications have not changed for at least 30 days Exclusion Criteria: - You have a history of seizures - You have an acute illness or infection - You have diabetes - You have untreated thyroid disease - You have a neurological condition other than SCI (Alzheimer's disease, dementia, stroke, multiple sclerosis, Parkinson's disease, etc.) - You have a history of heart or vascular disease (coronary artery disease, congestive heart failure, peripheral artery disease,) - You have a history of moderate or severe head trauma (TBI) or diagnosed with cognitive impairment - You have a present or history of a psychological disorder - You have contraindications to electricity over your spine - You are dependent on a ventilator to breathe or have an open tracheostomy site - You have a recent history of substance abuse (within the past 3 months) - You have open wounds over the spine at the level targeted for stimulation - You are pregnant |
Country | Name | City | State |
---|---|---|---|
United States | James J Peters VAMC | Bronx | New York |
Lead Sponsor | Collaborator |
---|---|
James J. Peters Veterans Affairs Medical Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Exercise Endurance Time | Total time (minutes) the participant is able to exercise during the submaximal arm cycle ergometry test. | During procedures (30 minutes) | |
Primary | Recovery Heart Rate | Total time (minutes) for heart rate to return to baseline levels after submaximal exertion. | During procedures (60 minutes) | |
Primary | Tcore | This outcome measure is measured in degrees Celsius. | During procedures (90 minutes) | |
Primary | Thermal Comfort | Feeling of comfort from: +3 (very comfortable) to -3 (very uncomfortable). | During procedures (90 minutes) | |
Secondary | Workload | This outcome is measured in Watts (highest watt obtained) | End of exercise (30 minutes) | |
Secondary | Rate of Perceived Exhaustion | This is measured on the Borg scale (06-20) higher number = harder perceived exertion | End of exercise (30 minutes) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02705755 -
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
|
Phase 2 | |
Recruiting |
NCT05941819 -
ARC Therapy to Restore Hemodynamic Stability and Trunk Control in People With Spinal Cord Injury
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT02897063 -
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
|
Phase 1 | |
Completed |
NCT02726776 -
Suspension Syndrome
|
N/A | |
Completed |
NCT01559675 -
Trial Comparing Low Dose and High Dose Steroids in Patients Undergoing Colorectal Surgery
|
N/A | |
Not yet recruiting |
NCT04440085 -
RaGuS Trial by Postoperative Patients
|
Phase 4 | |
Recruiting |
NCT03732716 -
Sarcopenia and Orthostatic Hypotension
|
||
Recruiting |
NCT05621460 -
The Effect of Water Carbonation on Orthostatic Tolerance
|
N/A | |
Completed |
NCT02632318 -
Dawn Simulation and Postural Hypotension
|
Phase 4 | |
Completed |
NCT05729724 -
Effect of Pharmacological Interventions on Systolic Blood Pressure Drops (SynABPM 2 Proof-of-concept)
|
||
Completed |
NCT03721393 -
Data Collection - Of Syncope Tilt Table Testing Study
|
||
Completed |
NCT01030874 -
Orthostatic Hypotension Treatment on Rehab Unit
|
N/A | |
Completed |
NCT01362751 -
Orthostatic Hypotension in Elderly Nursing Home Residents
|
N/A | |
Completed |
NCT01223391 -
Abdominal Compression in Orthostatic Hypotension
|
N/A | |
Completed |
NCT00248807 -
A Study of Blood Pressure and Blood Supply to the Brain in Persons With a Spinal Cord Injury.
|
N/A | |
Terminated |
NCT00137319 -
Impedance Threshold Device Tilt Study
|
N/A | |
Completed |
NCT05233865 -
Hemodynamic Effects During Land vs Water Exercise for Older Adults With Orthostatic Hypotension
|
N/A | |
Suspended |
NCT01370512 -
Droxidopa / Pyridostigmine in Orthostatic Hypotension
|
Phase 2 | |
Recruiting |
NCT00452712 -
Orthostatic Hypotension in Children With Acute Febrile Illness
|
Phase 2 |